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Available online 2 May 2019Background: Autoimmunity and allergy have been associated with decreased number and function of regulatory
T-cells (Tregs) and low interleukin-2 (IL-2) levels. We aimed to investigate if the release of IL-2 from peripheral
bloodmononuclear cells (PBMCs) stimulatedwith pathogenic airway bacteriawas associatedwith development
of allergy-outcomes in early childhood.
Methods: PBMCs were isolated at age 6 months in 331 infants from the Copenhagen Prospective Studies on
Asthma in Childhood 2000 (COPSAC2000) mother-child cohort, and subsequently stimulated with H. inﬂuenzae,
M. catarrhalis and S. pneumoniae in in vitro cultures. Levels of cytokines (IL-2, IL-10, IFN-γ, TNF-α, IL-5, IL-13
and IL-17A) were determined in the supernatant by electrochemiluminescence immunoassays. The immune
proﬁles were analyzed for association with development of total-IgE, allergic sensitization and rhinitis during
the ﬁrst 7 years of life using regression models and principal component analysis (PCA).
Findings:An attenuated IL-2 response to stimulationwithH. inﬂuenzae (p=0∙011) andM. catarrhalis (p=0∙027)
was associated with elevated total-IgE at age 7, which was conﬁrmed in a multivariate PCA model including all
cytokine measurements (PC2, p= 0∙032). An immune proﬁle with both reduced IL-2 and elevated IL-5 was as-
sociated with increased risk of allergic rhinitis (PC3, p = 0∙038). We found no associations with development of
allergic sensitization.
Interpretation: A reduced IL-2 response from PBMCs exposed to common pathogenic airway bacteria at age
6monthswas associatedwith elevated total-IgE and allergic rhinitis during the ﬁrst 7 years of life. These ﬁndings
suggest that suppressed Treg activity in early lifemay herald onset of allergy in early childhood, which could be a
target for low-dose IL-2 trials in the future.
Fund: COPSAC is funded by private and public research funds all listed on www.copsac.com.
© 2019 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Sensitization1. Introduction
Reduced numbers and function of regulatory T-cells (Tregs) have
been demonstrated in autoimmune and allergic diseases, suggesting
that a dysregulated Treg system contributes to the pathogenesis ofdies on Asthma in Childhood;
al Component Analysis; Treg,
spective Studies on Asthma in
openhagen, Ledreborg Alle 34,
en access article under the CC BY-NCthese conditions [1–4]. Interleukin 2 (IL-2) is critical for the develop-
ment and survival of Tregs [5–7] and a possible role of the IL-2/Treg in-
terplay in allergy has been suggested by a study showing that reduced
IL-2 expression by cord blood CD4(+) T cells associatedwith decreased
Tregs and increased risk of food allergy in childhood [8].
In the Copenhagen Prospective Studies on Asthma in Childhood
2000 (COPSAC2000)mother-child cohortwe conducted repeated clinical
assessments including total-IgE, speciﬁc-IgE, and allergic rhinitis
through age 7 and biobanking of peripheral blood mononuclear cells
(PBMCs) isolated from the infants at age 6 months. Recently, we inves-
tigated the PBMC response to in vitro stimulations with H. inﬂuenzae,
M. catarrhalis, and S. pneumoniae measuring production of T cell--ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Research in context
Evidence before this study
It is well known that T regulatory cell (Tregs) play important roles
in maintaining homeostasis of the immune system. Interleukin 2
(IL-2) is crucial for the development and survival of Tregs acting
via its high affinity receptor CD25 and it has been demonstrated
that low-dose IL-2 therapy results in significant expansion and ac-
tivation of Tregs. It has been shown in randomized placebo-
controlled trials that low dose IL-2 therapy is safe in humans and
has the capacity to successfully control the manifestation of sev-
eral diseases related to imbalanced immune responses, including
hepatitis C virus-mediated vasculitis, graft-versus-host disease,
alopecia areata and type I diabetes. Recently, it has been shown
that a disturbed IL-2/Treg interplay may be of importance in child-
hood allergy development as reduced IL-2 expression by cord
blood CD4(+) T cells was associated with decreased numbers
of Tregs and increased risk of subsequent food allergy in the
Barwon Infant study. Further, findings from a mouse model
showed that low dose IL-2 treatment could dampen the allergic in-
flammatory process by inducing expansion and activation of
Tregs. These findings suggest a potential application of low dose
IL-2 therapy for prevention and treatment of childhood allergy,
but further human studies are needed to disentangle the role of
IL-2 expression in early life in relation to the development of aller-
gic outcomes.
Added value of this study
In this study we investigated the functional immune properties of
peripheral blood mononuclear cells (PBMCs) from 6-month-old
healthy infants stimulated with pathogenic airway bacteria and
show that immune responses characterized by reduced produc-
tion of IL-2 are associated with development of elevated total-
IgE levels and allergic rhinitis during the first 7 years of life. This
suggests the existence of suppressed Treg activity in early life
heralding the onset of allergy outcomes during early childhood,
which may be reverted by low dose IL-2 therapy.
Implications of all the available evidence
These findings support the initiation of low dose IL-2 therapy trials
for preventing and treating childhood allergic airway disorders.
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tumor necrosis factor-α (TNF-α)), Th2 (IL-5, IL-13) and Th17 (IL-17A)
cells [9,10].
The aim of the current study is to analyze the relationship between
the PBMC response to bacterial stimulations and the development of
allergy-related endpoints during the ﬁrst 7 years of life, hypothesizing
a protective role of IL-2.
2. Materials and methods
2.1. Study cohort
This study is part of the ongoing COPSAC2000 prospective mother-
child cohort of 411 children born tomothers with asthma [11]. The chil-
dren were enrolled at age 1 month, excluded children born before ges-
tational week 36 and children suffering from any respiratory disorder
before enrollment. The children were followed prospectively at theCOPSAC clinical research unit with regular follow-up visits every
6months till age 7 and at episodeswith respiratory symptoms. The clin-
ical research unit was the primary health care facility for diagnosis and
treatment of any respiratory symptoms, strictly adhering to validated
algorithms [12].
The study was approved by the Copenhagen Ethics Committee (KF
01-289/96), the Danish Data Protection Agency (2002-41-2434), and
followed the principles of the Declaration of Helsinki. Written and oral
informed consent was obtained from the parents at enrolment.
2.2. Bacterial stimulation of PBMCs
The bacterial stimulations of PBMCs was previously described in de-
tails [9,10]. Brieﬂy, PBMCs were isolated by density centrifugation from
blood samples collected at 6 months and stored for up to 12 years at
-140 °C. After thawing, the cells were stimulated with UV-inactivated
H. inﬂuenzae,M. catarrhalis, and S. pneumoniae (50 μg/mL) or blank ster-
ile culture media alone in U-bottomed 96-well plates at 5 × 105 cells/
well (200 μL total volume/well) for 40 h at 37 °C and 5% CO2 in a humid-
iﬁed incubator. Supernatants were harvested and stored at−80 °C until
quantiﬁcation of IL-2, IL-10, IFN-γ, TNF-α, IL-5, IL-13 and IL-17A levels
by customized multiplex immunoassays from MesoScale Discovery
read on a Sector Imager 6000 (MSD, Gaithersburg, MD, USA). All assays
were highly sensitive with a detection limit below 1 pg/mL.
3. T cell immune phenotyping
The composition of the T cell compartment was analyzed on freshly
thawed unstimulated PBMCs (5 × 105 cells) using ﬂow cytometry.
Staining and ﬂow cytometry analysis were performed using the follow-
ing antibody panel: CD3/eFlour450, CD8/FITC, TCRVa24-Ja18/PerCP-
eFlour710, CD127/APC-eFlour780 (eBioscience, San Diego, CA), CD25/
PC7, TCRγδ/PE (Beckman Coulter, Brea, CA) and CD4/V500 (BD Biosci-
ence, San Jose, CA). T cell subsets were identiﬁed by a predeﬁned gating
strategy and analyzed in a blinded manner: Helper (CD3+CD4+), cyto-
toxic (CD3+CD8+), regulatory (CD3+CD4+CD127−CD25+), γδ (CD3+-
TCRγδ+) and invariant NK (CD3+TCRVα24-Jα18+) T cells. All
population frequencies were calculated relative to the CD3+ T cell
compartment.
3.1. Allergy-related endpoints
Total-IgE level was determined at 6 years by ImmunoCAP
(Pharmacia Diagnostics AB, Uppsala, Sweden) and analyzed as a contin-
uous variable.
Allergic sensitization was assessed at 6 years by skin prick tests
(SPT) and measurements of speciﬁc-IgE against house dust mites, cat,
dog, horse, birch, grass, mugwort, and molds as previous detailed [13].
SPT was done using allergen extracts (ALK Abello, Soluprick® SQ, Co-
penhagen, Denmark) deﬁning a positive test as any wheal ≥3 mm.
Speciﬁc-IgE levels were measured with ImmunoCAP (Thermo Fisher
Scientiﬁc, Uppsala, Sweden), deﬁning a positive test as any speciﬁc-
IgE level ≥ 0∙35kUA/L. Sensitization was analyzed as a dichotomized
variable, separately for SPT and speciﬁc-IgE as the overlap between
test results is poor at young age [14].
Allergic rhinitis at age 7 was diagnosed by the COPSAC pediatricians
based on a parental interview on the child's history of symptoms [15].
Signiﬁcant sneezing or blocked or runny nose affecting the wellbeing
of the child in the past 12months in periods without cold or ﬂu deﬁned
rhinitis. The diagnosis required sensitization and congruence between
symptoms and allergen exposure.
3.2. Statistical analysis
Initially, supernatant levels of cytokines in response to bacterial
stimulations were adjusted by subtracting the baseline levels of
Table 2
Composition of T cell compartment at 6 age months (n= 242).
T cell proﬁle Median (IQR)
Helper T cells (%) 68∙5(62∙6–72∙4)
Cytotoxic T cells (%) 24∙1(20∙6–29∙8)
Regulatory T cells (%) 2∙3(1∙8–2∙9)
γδ T cells (%) 3∙0(2∙2–3∙9)
Invariant NK T cells (%) 0∙1(0∙1–0∙1)
Values are percentage of all CD3+ T cells.
IQR = interquartile range.
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the levels were square root-transformed. If an individual did not pro-
duce a measurable cytokine response in PBMCs after bacterial stimula-
tion (non-responders), the cytokine level was set to zero.
First, we analyzed the association between the cytokines released
upon bacterial stimulations at 6 months and total-IgE level (log-trans-
formed), allergic sensitization by SPT (yes/no) and elevated speciﬁc-
IgE (yes/no), and allergic rhinitis (yes/no) during the ﬁrst 7 years of
life using linear and logistic regression models. The associations with
outcomes for cytokines from each bacterial stimulation were analyzed
using forward stepwise selection while retaining IL-2. If the ﬁnal
model had multiple independent variables they were compared with
a null model by ANOVA for goodness of ﬁt. If only IL-2 was retained in
theﬁnalmodel, the hypothesis test for its coefﬁcientwas used as assess-
ment of goodness of ﬁt. Only the models with signiﬁcant overall
p-values (≤0.05) are discussed in detail.
Thereafter, we conducted a data-driven principal component analy-
sis (PCA) on the 21 independent variables (3 bacterial stimulation x 7
different cytokines) to capture immune patterns in the data, using prin-
cipal component 1 to 4 (PC1–4) from themodel for association analyses
with the outcomes.
We also analyzed the association between T cell subsets and allergy-
related outcomes. T cell composition datawas transformed by isometric
log ratio (ilr) using sequential binary partitioning and their association
with outcomes was analyzed by multiple regression models [16].
All analyseswere conductedwith R version 3.4.2 [17]. The results are
reported with 95% CI and p-values ≤.05 were considered statistically
signiﬁcant.
4. Results
4.1. Baseline characteristics
A total of 331 (81%) of the 411 infants in the cohort had PBMCs col-
lected at age 6 months, which were subsequently exposed to
H. inﬂuenzae,M. catarrhalis, and S. pneumoniae for assessment of the im-
mune response bymeasuring supernatant cytokine levels. The T cell im-
mune phenotyping and immune responses are described in Tables 1–2.
Of the 331 infants, 259 (78%) had measurements of total-IgE (mean
level, 117∙6 IU/mL), 270 (82%) had SPT (N = 251) and/or sIgE (N =
259) with 100 (30%) being sensitized to one or more allergen either
by SPT (N = 40) and/or sIgE (N = 94). Allergic rhinitis was assessed
in 254 (77%) with a prevalence of 13% (N= 34) by age 7 years.
A comparison between children with vs. without immune response
data has previously been published showing no differences [9,10].
4.2. Bacteria-induced immune response and allergy-related outcomes
4.2.1. Total-IgE
Multiple regression analyses showed inverse associations between
IL-2 production in response to H. inﬂuenzae and M. catarrhalis at age
6 months and total-IgE level at age 6 years: IL-2-coefﬁcienthi =
−0∙183 [95% CI;−0∙324,−0∙043], p= 0∙011 and IL-2-coefﬁcientmc =
−0∙150 [−0∙282,−0∙018], p = 0∙027, respectively. The IL-2 associationTable 1
Supernatant cytokine levels in response to pathogenic airway bacteria at 6 months (n= 331).
Cytokine supernatant Control, median (IQR) H. inﬂuenzae, median (
IL-2 (pg/ml) 0∙8 (0–4∙2) 4∙8 (1∙2–14∙6)
IL-10 (pg/ml) 0∙0 (0–1) 15∙0 (2∙2–60∙2)
IFN-γ (pg/ml) 0∙4 (0–1) 4∙5 (0∙3–77∙9)
TNF-α (pg/ml) 1∙5 (0∙5–4∙1) 35∙5 (8∙2–169∙2)
IL-5 (pg/ml) 0∙0 (0∙0–0∙0) 0∙0 (0∙0–0∙4)
IL-13 (pg/ml) 0∙0 (0∙0–0∙0) 14∙9 (0∙0–75∙5)
IL-17A (pg/ml) 0∙0 (0∙0–1∙8) 1∙9 (0∙0–12∙6)
IQR = interquartile range.was only seen in response to the Gram-negative bacteria H. inﬂuenzae
(pFtest = 0∙028) andM. catarrhalis (PFtest = 0∙024), whereas the model
using cytokine data in response to the Gram-positive bacteria
S. pneumoniae was not better than the null model (PFtest = 0∙139):
IL-2-coefﬁcientsp = 0∙151 [0∙001, 0∙301], p= 0∙0503 (Fig. 1).
Besides IL-2, the production of IFN-Ƴ and TNF-α in response to
H. inﬂuenzae and M. catarrhalis were positively associated with total-
IgE level: IFN-Ƴ-coefﬁcienthi = 0∙019 [0∙000, 0∙0367], p = 0∙046, and
TNF-α-coefﬁcientmc = 0∙159 [0∙027, 0∙290], p = 0∙019, respectively.
The result of a PCA analysis to identify individual cytokine proﬁles in
response to the bacteria is depicted in Fig. 2 and Fig. e1. The PCA associ-
ation analysis for total-IgE conﬁrmed the ﬁndings from the regression
models. The cytokine pattern in PC2 from M. catarrhalis was inversely
associated with total-IgE level (p = 0∙032) and the same trend was
seen for PC2 from H. inﬂuenzae stimulation (p = 0∙051); i.e. higher
total-IgE was associated with a decreasing score dominated by IL-2
(Fig. 2).
4.2.2. Allergic sensitization
Higher IL-5 secretion in response to S. pneumoniaewas signiﬁcantly
associated with sensitization diagnosed by sIgE at age 6: ORsc = 1∙678
[1∙069, 2∙633], p = 0∙024, although the overall model with inclusion of
all cytokines was not signiﬁcantly better than the null model (overall
p-value = 0∙080). No associations were observed between the immune
response to the other bacterial stimulations and development of allergic
sensitization determined by neither sIgE nor SPT (Figs. 1–2).
4.2.3. Allergic rhinitis
IL-2 in response to M. catarrhalis and IL-13 in response to
H. inﬂuenzae were inversely associated with allergic rhinitis by age 7:
ORmc = 0∙495 [0∙273, 0∙898], p = 0∙021, and ORhi = 0∙429 [0∙197,
0∙933], p = 0∙033; i.e. higher IL-2 and IL-13 production reduced the
risk of allergic rhinitis. We also found that elevated IL-5 in response to
all the bacterial stimulations increased the risk of allergic rhinitis:
ORhi = 1∙954 [1∙037, 3∙681], phi = 0∙038, ORmc = 1∙569 [1∙056, 2∙330],
pmc=0∙026, and ORsp=1∙614 [1∙070, 2∙434], psp= 0∙022. Themultiple
regression models were all signiﬁcantly better than the null models:
pchisq = 0∙048 for H. inﬂuenzae, pchisq = 0∙017 for M. catarrhalis, and
pchisq = 0∙046 for S. pneumoniae (Fig. 1).
The results from the PCA supported the main ﬁndings from the
regression analyses regarding IL-5 and IL-2, but not for IL-13. We
found an inverse association between development of allergic rhi-
nitis and the immune pattern in PC3 uponM. catarrhalis stimulationIQR) M. catarrhalis, median (IQR) S. pneumoniae, median (IQR)
12∙2 (3∙2–28∙5) 9∙5 (1∙4–41∙8)
22∙5 (3∙9–77∙6) 1∙8 (0–9∙9)
19∙9 (0∙8–233∙9) 1∙4 (0∙2–12∙2)
54∙2 (17∙7–201∙7) 21∙5 (5∙2–101)
0∙4 (0∙0–2∙4) 0∙0 (0∙0–0∙6)
60∙4 (5∙7–203∙3) 10∙9 (0∙0–71∙6)
9∙4 (0∙5–43∙0) 2∙2 (0∙0–17∙6)
Fig. 1. Association between selected cytokines and allergic outcomes. Association between cytokines from 6 month (n = 331) upon stimulation with H. inﬂuenzae, M. catarrhalis and
S. pneumoniae and log transformed total IgE (mean = 1.505, SD = 1.115), allergic sensitization determined by skin prick test (case/control = 44/173) and speciﬁc-IgE level (case/
control = 93/173) at 6 year, and allergic rhinitis (case/control = 38/185) at 7 year. The shown cytokines were from the best ﬁtted models, which were deﬁned by forward stepwise
regression in relation to each clinical outcomes. Ordinary least squares regression for log transformed total-IgE level and logistic regression for the rest of allergy outcomes was each
regressed on cytokines from each stimulation in a forward stepwise fashion by retaining IL-2 in the selection process. The overall ﬁtness of selected models was accessed and relevant
model statistics (Odds Ratio (OR) for binary outcomes, coefﬁcients for continuous outcome and their associated 95% conﬁdence intervals) for signiﬁcant ones were shown in solid
colors and bigger dot size, otherwise the colors were faint and the dots were smaller. Positive SPT= positive skin prick test, hi = H. inﬂuenzae, mc=M. catarrhalis, sp= S. pneumoniae.
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increased the risk of allergic rhinitis at age 7. In addition, a decreas-
ing PC4 score from the H. inﬂuenzae stimulation was signiﬁcantly
associated with risk of allergic rhinitis, i.e. lower IL-17A and higher
IFN-γ release increased the risk of allergic rhinitis (p = 0∙048)
(Fig. 2).
4.2.4. Sensitivity analysis
Asmany of the children did not produce any IL-5 in PBMCs after bac-
terial stimulations (IL-5 non-responders), we conducted a sensitivity
analysis excluding these (Table e1). This showed similar results for the
univariate association between IL-5 and allergic rhinitis by age 7:
ORhi = 2∙532 [1∙127, 5∙690], phi = 0∙025, ORmc = 3∙231 [1∙274, 8∙200],
pmc=0∙014, andORsp=1∙729 [1∙084, 2∙757], psp=0∙021, and themul-
tiple regression models were also signiﬁcantly better than the null
models: pchisq = 0∙040 for H. inﬂuenzae, pchisq = 0∙001 for
M. catarrhalis, and pchisq=0∙048 for S. pneumoniae (Fig. e2). The PCA re-
sults were consistent showing an inverse association between allergic
rhinitis and the immune pattern in PC3 upon stimulations from both
M. catarrhalis (p= 0∙036) and H. inﬂuenzae (p= 0∙038) (Fig. e3).
4.3. T cell compartment composition
To study if the cytokine response proﬁles were related to an under-
lying difference in T cell subsets, we examined the T cell compartment
composition in relation to the allergy-outcomes. The relative ratios of
γδ T cells and iNKT cells amongst all T cells were associated with
total-IgE level at age 6, but in opposite directions with an inverse asso-
ciation identiﬁed for iNKT cells (p= 0∙030), and positive association for
γδ T cells (p = 0∙022) (Fig. 3, Fig. e4). No associations between the rel-
ative ratio of Tregs and development of allergy-related outcomes were
observed (Fig. 3).
5. Discussion
5.1. Main ﬁndings
An attenuated IL-2 response to stimulationwith the commonGram-
negative pathogenic airway bacteria H. inﬂuenzae and M. catarrhalis in
PBMCs collected at age 6 months was associated with elevated total-IgE at age 6 years. Furthermore, both reduced IL-2 and increased IL-5
productionwere associatedwith a higher risk of developing allergic rhi-
nitis during the ﬁrst 7 years of life. Altogether, these ﬁndings suggest a
role of diminished IL-2 and increased IL-5 in development of allergy-
related traits in early childhood.5.2. Strengths and limitations
This is theﬁrst prospective cohort study to investigate infant's bacte-
rial immune responses in PBMCs, which was done in a comprehensive
manner by analyzing several cytokines of the Treg, Th1, Th2, and Th17
cells. The prospective nature of our study and the storage of PBMCs at
age 6 months provide a unique possibility to investigate functional im-
munological properties in infancy before onset of allergy-related out-
comes. As the PBMCs were collected in asymptomatic infants before
onset of allergic disease, the bacterial immune response is unlikely to
be affected by immune dysfunction caused by ongoing disease-driven
inﬂammation.
It is an advantage of the study that the children participating in the
COPSAC2000 cohort solely used the COPSAC researchpediatricians for di-
agnosis and treatment of any asthma and allergy-related disease. All di-
agnoses were done based on rigid standardized algorithms providing
highly reliable homogeneous clinical outcomes.
It is a limitation that this was an in vitro study that may not reﬂect
the complexity of the immune responses in vivo. Importantly, many of
the infants stored PBMCs did not produce a measurable IL-5 response
to any of the bacterial stimulations. However, analyses including the
IL-5 non-responders as zeros as well as analyses excluding the non-
responders showed similar associations with the clinical endpoints.
It is a limitation that the results are based on one concentration of
antigen performed at one time point (40 h culture). Therefore, we are
not able to determine how the results would look like at different
time points and by stimulating with different concentrations, which is
particularly important for IL-2,which is consumed in the cultures. How-
ever, this would have been of greater importance if we had not detected
an association between IL-2 PBMC responses and allergy-outcomes.
Finally, it is a limitation that all the children participating in the co-
hort were born tomotherswith a history of asthma,whichmay hamper
the external validity of our ﬁndings.
Fig. 2. Association between cytokine proﬁles from 6 month (n = 331) upon stimulation with H. inﬂuenzae, M. catarrhalis and S. pneumoniae and log transformed total IgE, allergic
sensitization determined by skin prick test and speciﬁc-IgE level at age 6 and allergic rhinitis at age 7. A. Cytokine loadings of PC1 to PC4 from principal components analysis (PCA). B.
Ordinary least squares regression for log-transformed total-IgE level and simple logistic regression for the rest clinical outcomes was each regressed on PC1–4. The values of test
statistic of regression coefﬁcients are plotted in the heatmaps. Blue indicates negative association and red indicate positive association. Asterixis (*) indicates p b .05. hi = H.
inﬂuenzae. mc = M. catarrhalis. sp = S. pneumoniae. Log transformed total IgE (mean = 1.505, sd = 1.115). Number of allergic rhinitis and control (38/185). Number of Kids with
allergic sensitization assessed by the level of speciﬁc IgE and healthy control (93/173). Number of Kids with allergic sensitization assessed by skin prick test (SPT) and healthy control
(44/173).
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In this study, we aim to identify immune patterns in infancy in re-
sponse to different bacteria in relationwith development of allergic dis-
orders in the ﬁrst 7 years of life. The bacterial stimulations were chosen
aswe previously demonstrated that one-month-old infants colonized in
the airways with H. inﬂuenzae,M. catarrhalis, and/or S. pneumoniae had
an increased risk of asthma at age 5 years [18]. However, no direct link
was shown between neonatal airway colonization with these bacteria
and allergic outcomes, but studies indicate that environmental expo-
sure to certain bacteria or bacterial components like lipopolysaccharide,
which is contained in H. inﬂuenzae and M. catarrhalis, are associated
with risk of allergic sensitization in childhood [19–21].
We speculate that our ﬁnding of a reduced IL-2 production in
concert with increased IL-5 to stimulations with the Gram-negative
bacteria H. inﬂuenzae and M. catarrhalis may be caused by imbal-
anced Treg and Th2 populations and thereby increase the risk of de-
veloping allergic diseases. This ﬁnding may be of clinical importance
as low-dose IL-2 therapy is being investigated with the purpose of
expanding the Treg population in several diseases. We did not ob-
serve similar ﬁndings when analyzing the cytokine responses fromthe Gram-positive S. pneumonia stimulation, which may be due to
the fact that this bacteria does not contain the innate immune ligand
lipopolysaccharide.
Recent clinical trials have studied the tolerability and efﬁcacy of low-
dose IL-2 therapy in the treatment of autoimmune disorders and graft-
versus-host disease [22–25]. All trials reported the therapy to be safe
and effective in mediating sustained expansion of systemic Tregs with
clinically relevant improvement in patientswithHCV-induced vasculitis
[22], alopecia areata [25], and graft-versus-host disease [24]. We specu-
late that low-dose IL-2 therapymay have a beneﬁcial role on allergy and
propose initiation of clinical trials in children with allergy and subse-
quently trials investigating low-dose IL-2 as a possible therapeutic in-
tervention or a prophylactic regimen in high-risk infants. Due to the
proposed early window of immune programming for regulatory T cell
development [26], it might be speculated to be even more important
to propagate Treg development in early infancy, once an impaired IL-2
production has been detected. We here addressed the question of IL-2
production in PBMCs collected at 6 months of age, as bacteria-speciﬁc
T cells will have been expanded at this age if the child has been exposed
to the given bacteria in vivo. This is in contrast to studies performed on
cord blood. We selected a relatively short stimulation protocol of 40 h
Fig. 3.Theassociation between T cell compartment at 6month and allergy outcomes at the
age of 6 years. Multiple linear regression for log transformed total-IgE level and multiple
logistic regression for the rest of allergy outcomes was regressed on isometric
transformed T cell compartments. The values of test statistic of regression coefﬁcients
are plotted in the heatmaps. Blue indicates negative association and red indicate positive
association. Asterixis (*) indicates p b .05.
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effector T cells present in the PBMC fraction that would be more readily
activated for cytokineproduction thannaïve T cells,which require a lon-
ger protocol. Although this study examines immuneprogrammingprior
to disease development, it might also be valuable to use IL-2 therapy in
already diseased individuals. Prior to trials in allergic diseases, it would
valuable to investigate IL-2 PMBC responses in childrenwith vs.without
ongoing symptoms of allergic rhinitis.
Although IL-2 has pleiotropic effects and works on other types of Th
effectors, the efﬁcacy and speciﬁcity of low dosage IL-2 therapy may be
supported by the selective responsiveness of Tregs against low does
IL-2. It was reported that due to an enhanced expression of the IL-2 re-
ceptor (α and γ chain) and promoted activity of endogenous serine/
threonine phosphatase protein phosphates 1 and/or 2A in Tregs about
10–100 fold lower levels of IL-2 was required to activate STAT5 in
Tregs compared to the levels needed for memory T cells or activated T
cells [27].
It is possible that reduced IL-2 production during the continuous im-
mune activation induced by the hostmicrobiome in infancy could affect
the risk of developing allergic disease. It is recognized that the
microbiome plays a key role in development of the immune system
and the establishment of homeostatic tolerance by Tregs [28–30].
Thus, infants who respond to bacteria with lower IL-2 production
could have an imbalanced immune system with blunted Treg function
leading to proneness to develop higher circulating IgE levels, dimin-
ished control of tolerance to allergens, and subsequently develop symp-
tomatic disease such as rhinitis.
We have previously within the same cohort reported abnormal bac-
terial immune response in PBMCs in infants developing asthma later in
childhood [9]. The immune responses associated with asthma were
dominated by increased Th2 cytokines (IL-5 and IL-13) in response to
the same three pathogenic airway bacteria. However, in contrast to
the current ﬁndings, no associations existed between IL-2 release and
development of asthma, which underlines different immune patterns
driving the heterogeneous phenotypes of allergy and asthma and sug-
gests that low-dose IL-2 therapy might be targeted solely to the allergic
phenotype. This ﬁts well with a recent study from a food allergy mouse
model showing that low dose IL-2 treatment could control the allergic
inﬂammatory process by inducing expansion and activation of the
Treg population [31]. In linewith this, a very recent studywith amurine
respiratory allergy model also showed that application of IL-2-αIL-2
mAb complexes resulted in speciﬁcally induction of Treg population
and protection from airway hyperresponsiveness thereafter [32].Further experimental studies of i.e. allergen-speciﬁc stimulations of
human PBMCs are needed to determine whether IL-2 therapy should
solely be targeted to the allergic phenotype.
Higher IL-13 production upon bacterial stimulation of the PBMCs
was observed to reduce the risk of allergic rhinitis, which was however
not signiﬁcant in the multivariate PCA approach. This is an unexpected
ﬁnding as co-expression of IL-4, IL-13 and IL-5 are normally observed
in patients with ongoing symptoms of rhinitis. A non-coordinate ex-
pression of IL-4, IL-13 and IL-5 can occur when distinct Th2 clones pro-
duce each cytokine individually. Thus, the discrepancy in expression of
IL-5 and IL-13 may suggest a transient expression pattern associated
with the initial stage of Th2 priming as we investigated the response
from stimulated PBMCs in 6-month-old asymptomatic infants long be-
fore onset of any symptoms of allergic rhinitis.
Our T cell compartment data showed an association between the
composition of γδ T cells and total-IgE level suggesting a possible func-
tion of γδ T cells in the development of allergic diseases. Such associa-
tion has previously been reported in children with atopic dermatitis
aged 1 to 10 years, whereas no association was observed for total-IgE
level within these children with atopic dermatitis [33]. Finally, we also
identiﬁed an inverse association between the composition of iNKT
cells and total-IgE, which is consistent with previous ﬁndings in adult
asthmatics [34].6. Conclusion
Reduced IL-2 production and increased IL-5 fromPBMCs in response
to bacterial stimulations in early life were associated with development
of elevated total-IgE and allergic rhinitis during the ﬁrst 7 years of life.
This ﬁnding is of possible clinical relevance as experimental studies
have shown that low-dose IL-2 therapy can restore immune tolerance
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